Login

BioMed Realty Trust Inc 3 SEC Filings

Filed On Filing
17 Apr 2015 Form 3: Berens James R, President, Wexford

Holds 34,828 shares of Common Stock

18 Feb 2015 Form 3: Sztraicher Karen A, EVP, Asset Management

Holds 104,850 shares of Common Stock

18 Feb 2015 Form 3: Bonanno John P, EVP, Leasing & Development

Holds 78,855 shares of Common Stock

18 Feb 2015 Form 3: Klassen Jonathan Paul, EVP, Gen Coun & Sec

Holds 56,990 shares of Common Stock

26 Jan 2015 Form 3: BioMed Realty Trust Inc, 10% owner and 1 other · Zosano Pharma Corp

Holds 454,243 shares of Common Stock

08 Apr 2014 Form 3: Sears Janice L., Director

No securities owned

18 Dec 2013 Form 3: Brody William R Md Phd, Director

No securities owned

03 Jan 2013 Form 3: Bradbury Daniel, Director

No securities owned

04 Oct 2011 Form 3: BioMed Realty Trust Inc, 10% owner · Adhera Therapeutics, Inc.

Holds 9,915,727 shares of Common Stock

14 Dec 2010 Form 3: Willey Stephen A., VP, Chief Accounting Officer

Holds 33,118 shares of Common Stock

14 Dec 2007 Form 3: Gilchrist Richard I, Director

No securities owned

04 Apr 2007 Form 3: Lubushkin Greg, VP- Chief Accounting Officer

No securities owned

28 Mar 2006 Form 3: Griffin R Kent Jr, Chief Financial Officer

No securities owned

07 Oct 2005 Form 3: Sztraicher Karen A, VP - Chief Accounting Officer

Holds 11,300 shares of Common Stock

12 Jan 2005 Form 3: Wilson Margaret Faye, Director

No securities owned

05 Aug 2004 Form 3: Wilson John F Ii, Chief Financial Officer

No securities owned

05 Aug 2004 Form 3: Roth Theodore D, Director

No securities owned

05 Aug 2004 Form 3: Riedy Mark J, Director

No securities owned

05 Aug 2004 Form 3: McDevitt Matthew G, Vice President, Acquisitions

No securities owned

05 Aug 2004 Form 3: Kreitzer Gary A, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support